Robert E. W. Hancock
TitelZitiert vonJahr
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover, XQ Pham, AL Erwin, SD Mizoguchi, P Warrener, MJ Hickey, ...
Nature 406 (6799), 959, 2000
41752000
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
REW Hancock, HG Sahl
Nature biotechnology 24 (12), 1551, 2006
29922006
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
I Wiegand, K Hilpert, REW Hancock
Nature protocols 3 (2), 163, 2008
24442008
Peptide antimicrobial agents
H Jenssen, P Hamill, REW Hancock
Clinical microbiology reviews 19 (3), 491-511, 2006
20922006
Cationic peptides: a new source of antibiotics
REW Hancock, R Lehrer
Trends in biotechnology 16 (2), 82-88, 1998
15691998
Peptide antibiotics
REW Hancock, DS Chapple
Antimicrobial agents and chemotherapy 43 (6), 1317-1323, 1999
15331999
Peptide antibiotics
REW Hancock
The Lancet 349 (9049), 418-422, 1997
14071997
The role of cationic antimicrobial peptides in innate host defences
REW Hancock, G Diamond
Trends in microbiology 8 (9), 402-410, 2000
12672000
Cationic peptides: effectors in innate immunity and novel antimicrobials
REW Hancock
The Lancet infectious diseases 1 (3), 156-164, 2001
10592001
Designing antimicrobial peptides: form follows function
CD Fjell, JA Hiss, REW Hancock, G Schneider
Nature reviews Drug discovery 11 (1), 37, 2012
10542012
The role of antimicrobial peptides in animal defenses
REW Hancock, MG Scott
Proceedings of the national Academy of Sciences 97 (16), 8856-8861, 2000
10302000
The relationship between peptide structure and antibacterial activity
JPS Powers, REW Hancock
Peptides 24 (11), 1681-1691, 2003
8742003
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
AK Marr, WJ Gooderham, REW Hancock
Current opinion in pharmacology 6 (5), 468-472, 2006
8422006
Cationic host defense (antimicrobial) peptides
KL Brown, REW Hancock
Current opinion in immunology 18 (1), 24-30, 2006
7702006
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram-Negative Bacteria
REW Hancock
Clinical Infectious Diseases 27 (Supplement_1), S93-S99, 1998
7361998
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli
M Wu, E Maier, R Benz, REW Hancock
Biochemistry 38 (22), 7235-7242, 1999
7291999
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
MG Scott, DJ Davidson, MR Gold, D Bowdish, REW Hancock
The journal of immunology 169 (7), 3883-3891, 2002
6742002
Pseudomonas aeruginosa: all roads lead to resistance
EBM Breidenstein, C de la Fuente-Núñez, REW Hancock
Trends in microbiology 19 (8), 419-426, 2011
6542011
Biochemical model for enhanced biological phosphorus removal
Y Comeau, KJ Hall, REW Hancock, WK Oldham
Water Research 20 (12), 1511-1521, 1986
6391986
Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.
RP Darveau, RE Hancock
Journal of bacteriology 155 (2), 831-838, 1983
6361983
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20